Aldeyra Therapeutics (ALDX) Operating Leases (2019 - 2025)
Aldeyra Therapeutics' (ALDX) quarterly Operating Leases came in at $72536.0 in Q3 2025, up 3.28% YoY from $70234.0 in Q3 2024, and down 49.43% on a QoQ basis from $143447.0 in Q2 2025.
Aldeyra Therapeutics (ALDX) Operating Leases (2019 - 2025) Analysis & Trends
Aldeyra Therapeutics (ALDX) has 6 years of Operating Leases data on file, last reported at $72536.0 in Q3 2025.
- Quarterly Operating Leases rose 3.28% year-over-year to $72536.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $72536.0 (up 3.28% YoY) and the FY2023 annual result came in at $271631.0, changed N/A from the prior year.
- Operating Leases slipped to $72536.0 in Q3 2025, from $143447.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $271631.0 in Q4 2023 to a low of $63325.0 in Q1 2022.
- A 5-year average of $148868.0 and a median of $141170.0 in 2024 frame the typical range for Operating Leases.
- The widest YoY moves for Operating Leases: up 3.28% in 2025, down 3.28% in 2025.
- Tracing ALDX's Operating Leases over 5 years: stood at $125232.0 in 2021, then slumped by 49.43% to $63325.0 in 2022, then surged by 328.95% to $271631.0 in 2023, then tumbled by 74.14% to $70234.0 in 2024, then advanced by 3.28% to $72536.0 in 2025.
- The last three Operating Leases figures came in at $72536.0 (Q3 2025), $143447.0 (Q2 2025), and $212769.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Aldeyra Therapeutics | 91.08 Mn | 91.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 72,536.00 |
| Jun 30, 2025 | 143,447.00 |
| Mar 31, 2025 | 212,769.00 |
| Sep 30, 2024 | 70,234.00 |
| Jun 30, 2024 | 138,893.00 |
| Mar 31, 2024 | 206,014.00 |
| Dec 31, 2023 | 271,631.00 |
| Mar 31, 2022 | 63,325.00 |
| Dec 31, 2021 | 125,232.00 |
| Sep 30, 2021 | 184,599.00 |
| Sep 30, 2019 | 58,720.00 |
| Jun 30, 2019 | 116,124.00 |
| Mar 31, 2019 | 156,808.00 |